NO801196L - Fremgangsmaate ved fremstilling av piperazinoquinazolin derivater - Google Patents

Fremgangsmaate ved fremstilling av piperazinoquinazolin derivater

Info

Publication number
NO801196L
NO801196L NO801196A NO801196A NO801196L NO 801196 L NO801196 L NO 801196L NO 801196 A NO801196 A NO 801196A NO 801196 A NO801196 A NO 801196A NO 801196 L NO801196 L NO 801196L
Authority
NO
Norway
Prior art keywords
piperazinoquinazoline
derivatives
procedure
preparation
piperazinoquinazoline derivatives
Prior art date
Application number
NO801196A
Other languages
English (en)
Other versions
NO152508C (no
NO152508B (no
Inventor
Simon Fraser Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO801196(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NO801196L publication Critical patent/NO801196L/no
Publication of NO152508B publication Critical patent/NO152508B/no
Publication of NO152508C publication Critical patent/NO152508C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO801196A 1979-04-25 1980-04-24 Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat NO152508C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (3)

Publication Number Publication Date
NO801196L true NO801196L (no) 1980-10-27
NO152508B NO152508B (no) 1985-07-01
NO152508C NO152508C (no) 1985-10-09

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801196A NO152508C (no) 1979-04-25 1980-04-24 Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperazinoquinazolinderivat

Country Status (33)

Country Link
US (1) US4279910A (no)
JP (1) JPS55145684A (no)
KR (1) KR830002567B1 (no)
AR (1) AR224400A1 (no)
AT (1) AT373596B (no)
BE (1) BE882967A (no)
CA (1) CA1132558A (no)
CH (1) CH642076A5 (no)
CS (1) CS209950B2 (no)
DD (1) DD150202A5 (no)
DE (1) DE3015676A1 (no)
DK (1) DK121080A (no)
EG (1) EG14651A (no)
ES (1) ES8101588A1 (no)
FI (1) FI64592C (no)
FR (1) FR2455042A1 (no)
GB (1) GB2049683B (no)
GR (1) GR68049B (no)
HU (1) HU184747B (no)
IE (1) IE49705B1 (no)
IL (1) IL59900A (no)
IT (1) IT1141490B (no)
LU (1) LU82394A1 (no)
NL (1) NL182563C (no)
NO (1) NO152508C (no)
NZ (1) NZ193511A (no)
PH (1) PH15156A (no)
PL (1) PL121470B1 (no)
PT (1) PT71139A (no)
SE (1) SE435061B (no)
SU (1) SU915804A3 (no)
YU (1) YU41709B (no)
ZA (1) ZA802488B (no)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
FI64592B (fi) 1983-08-31
CA1132558A (en) 1982-09-28
JPS5738591B2 (no) 1982-08-16
JPS55145684A (en) 1980-11-13
DK121080A (da) 1980-10-26
PT71139A (en) 1980-05-01
GR68049B (no) 1981-10-29
CS209950B2 (en) 1981-12-31
HU184747B (en) 1984-10-29
DD150202A5 (de) 1981-08-19
IL59900A (en) 1983-11-30
NZ193511A (en) 1982-03-30
PL121470B1 (en) 1982-05-31
IT8021598A0 (it) 1980-04-23
NL182563B (nl) 1987-11-02
PL223755A1 (no) 1981-02-13
NL8002387A (nl) 1980-10-28
NL182563C (nl) 1988-04-05
SE435061B (sv) 1984-09-03
FI64592C (fi) 1983-12-12
NO152508C (no) 1985-10-09
GB2049683A (en) 1980-12-31
IT1141490B (it) 1986-10-01
SE8003122L (sv) 1980-10-26
KR830002567B1 (ko) 1983-11-14
ATA218980A (de) 1983-06-15
ES490867A0 (es) 1980-12-16
YU113180A (en) 1983-02-28
SU915804A3 (en) 1982-03-23
PH15156A (en) 1982-08-24
BE882967A (fr) 1980-10-24
FR2455042B1 (no) 1983-05-20
AT373596B (de) 1984-02-10
NO152508B (no) 1985-07-01
KR830002758A (ko) 1983-06-30
YU41709B (en) 1987-12-31
IE49705B1 (en) 1985-11-27
ES8101588A1 (es) 1980-12-16
AR224400A1 (es) 1981-11-30
CH642076A5 (de) 1984-03-30
FI801306A (fi) 1980-10-26
IL59900A0 (en) 1980-06-30
DE3015676A1 (de) 1980-11-13
EG14651A (en) 1985-03-31
LU82394A1 (fr) 1980-07-31
GB2049683B (en) 1983-01-26
FR2455042A1 (fr) 1980-11-21
US4279910A (en) 1981-07-21
IE800827L (en) 1980-10-25
ZA802488B (en) 1981-08-26

Similar Documents

Publication Publication Date Title
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO803868L (no) Fremgangsmaate ved fremstilling av nye kinazolinderivater
NO800830L (no) Fremgangsmaate ved fremstilling av glycinamidderivater
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO802073L (no) Fremgangsmaate ved fremstilling av antihypertensive amider
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
NO801285L (no) Fremgangsmaate ved fremstilling av fenyletylaminderivater
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
NO802402L (no) R fremgangsmaate ved fremstilling av nye halovincamonderivate
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO802834L (no) Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider
NO781554L (no) Fremgangsmaate ved fremstilling av aminoalkoholderivater
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO793103L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO784235L (no) Fremgangsmaate ved fremstilling av benzazepin-derivater